ADAR1 Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001940272

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2024 · 203 positions · Total reported value $410.61M · Top-10 concentration 46.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.5% · 33 new · 62 cut · 48 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.0% · vs SPY -9.1% · Prev Value $1.81B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.7% · vs SPY -5.9% · Latest Value $1.82B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, ADAR1 Capital Management, LLC disclosed 203 equity positions with a combined reported value of $410.61M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were ROIV ($41.51M), BOXX ($35.89M), ZLAB ($27.39M). By sector, the heaviest allocations are Health Care 69.5%, Financials 1.8%. Versus the prior quarter, allocation shifted toward Other (+5.2pp), Financials (+1.8pp) and away from Health Care (-7.1pp).

Versus the prior quarter, ADAR1 Capital Management, LLC opened 33 new positions, trimmed 62 and fully exited 48, a turnover rate of 47.5% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q4 2024 were IKT ($16.58M), AVR ($5.88M), RCUS ($5.48M).

Of the 48 positions fully exited versus the prior quarter, the largest were QTTB ($2.87M), PIRS ($2.40M), SNDX ($2.02M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • IKT INHIBIKASE THERAPEUTICS INC · $16.58M
  • AVR ANTERIS TECHNOLOGIES GLOBAL · $5.88M
  • RCUS ARCUS BIOSCIENCES INC · $5.48M
  • OACCU OAKTREE ACQUISITION CORP III · $5.07M
  • SNY SANOFI SA · $4.80M
  • MNPR MONOPAR THERAPEUTICS INC · $2.86M
  • ASPCU A SPAC III ACQUISITION CORP · $2.17M
  • PVLA PALVELLA THERAPEUTICS INC NE · $1.74M

Fully Exited (vs previous quarter)

  • QTTB Q32 BIO INC · prev qtr: $2.87M
  • PIRS PIERIS PHARMACEUTICALS INC · prev qtr: $2.40M
  • SNDX SYNDAX PHARMACEUTICALS INC · prev qtr: $2.02M
  • NVO NOVO-NORDISK A S · prev qtr: $1.19M
  • BNTX BIONTECH SE · prev qtr: $1.19M
  • NVNO ENVVENO MEDICAL CORPORATION · prev qtr: $1.17M
  • PCVX VAXCYTE INC · prev qtr: $1.15M
  • NUVL NUVALENT INC · prev qtr: $1.07M

Insider Transactions (Form 4)

Latest ADAR1 Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-11 Buy NextCure, Inc. 12,333 $5.10 SEC filing
2026-11-06 Buy NextCure, Inc. 3,662 $5.10 SEC filing
2026-11-05 Buy InMed Pharmaceuticals Inc. 2,640 $13.10 SEC filing
2026-11-05 Buy NextCure, Inc. 1,024 $5.10 SEC filing
2026-10-27 Buy NextCure, Inc. 3,553 $5.10 SEC filing
2026-10-26 Buy NextCure, Inc. 1,672 $5.03 SEC filing
2026-10-23 Buy InMed Pharmaceuticals Inc. 4 $1.32 SEC filing
2026-10-23 Buy NextCure, Inc. 5,626 $4.83 SEC filing

All insider transactions →

Fund Profile

ADAR1 Capital Management, LLC is an SEC-registered 13F filer based in Austin, TX, United States. As of Q2 2026 it reported 268 US equity positions with a combined value of $1.81B. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Firm Snapshot

  • Headquarters: AUSTIN, TX, United States
  • SEC registration: 801-130082 (status: Approved), registered 2024-04-25
  • Regulatory AUM (Form ADV): $1.68B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 268 positions · $1.81B reported value (Q2 2026)
  • Top 10 holdings = 34.2% of reported value
  • Largest position: PTGX (PROTAGONIST THERAPEUTICS INC) at 6.5%
  • Average position size: $6.74M

Sector Tilt

  • Health Care 86.5%
  • Financials 2.6%
  • Industrials 0.4%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 42 new, 99 added, 60 reduced, 69 exited
  • 67 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 69.5%
Financials 1.8%
Materials 0.3%
Utilities 0.0%
Energy 0.0%
Technology 0.0%
Other 28.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.51M $41.51M 10.11%
10.11%
Add
2 325.45K $35.89M 8.74%
8.74%
Add
3 1.05M $27.39M 6.67%
6.67%
Add
4 787.48K $19.51M 4.75%
4.75%
Add
5 5.10M $16.58M 4.04%
4.04%
New
6 131.79K $12.05M 2.93%
2.93%
Add
7 1.51M $11.08M 2.70%
2.70%
Add
8 841.54K $10.36M 2.52%
2.52%
Add
9 71.40K $9.83M 2.39%
2.39%
Reduce
10 750.00K $7.63M 1.86%
1.86%
Hold
11 170.00K $7.44M 1.81%
1.81%
Add
12 1.36M $6.66M 1.62%
1.62%
Reduce
13 210.73K $6.59M 1.61%
1.61%
Add
14 215.75K $6.19M 1.51%
1.51%
Add
15 1.05M $5.88M 1.43%
1.43%
New
16 560.20K $5.66M 1.38%
1.38%
Reduce
17 5.62M $5.48M 1.33%
1.33%
New
18 234.61K $5.39M 1.31%
1.31%
Reduce
19 2.08M $5.19M 1.26%
1.26%
Reduce
20 132.00K $5.10M 1.24%
1.24%
Reduce
21 1.55M $5.08M 1.24%
1.24%
Reduce
22 500.00K $5.07M 1.23%
1.23%
New
23 40.00K $4.86M 1.19%
1.19%
Add
24 99.60K $4.80M 1.17%
1.17%
New
25 50.00K $4.50M 1.10%
1.10%
Add
26 404.14K $4.24M 1.03%
1.03%
Hold
27 515.14K $4.03M 0.98%
0.98%
Add
28 81.46K $3.43M 0.83%
0.83%
Reduce
29 166.41K $3.29M 0.80%
0.80%
Reduce
30 647.96K $3.23M 0.79%
0.79%
Add
31 146.67K $3.23M 0.79%
0.79%
Add
32 988.47K $3.03M 0.74%
0.74%
Add
33 773.63K $2.89M 0.70%
0.70%
Reduce
34 130.04K $2.86M 0.70%
0.70%
New
35 53.12K $2.72M 0.66%
0.66%
Reduce
36 58.71K $2.71M 0.66%
0.66%
Reduce
37 211.40K $2.66M 0.65%
0.65%
Add
38 154.03K $2.58M 0.63%
0.63%
Add
39 928.02K $2.46M 0.60%
0.60%
Add
40 57.98K $2.21M 0.54%
0.54%
Add
41 48.02K $2.17M 0.53%
0.53%
Add
42 215.00K $2.17M 0.53%
0.53%
New
43 2.00M $2.10M 0.51%
0.51%
Add
44 50.55K $1.98M 0.48%
0.48%
Add
45 41.27K $1.87M 0.46%
0.46%
Reduce
46 1.17M $1.86M 0.45%
0.45%
Add
47 149.38K $1.80M 0.44%
0.44%
Add
48 134.80K $1.78M 0.43%
0.43%
Reduce
49 144.64K $1.74M 0.42%
0.42%
New
50 30.94K $1.73M 0.42%
0.42%
New

FAQ

What did ADAR1 Capital Management, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, ADAR1 Capital Management, LLC reported 203 equity positions worth $410.61M in aggregate; its largest disclosed positions were ROIV ($41.51M), BOXX ($35.89M), ZLAB ($27.39M).

How large is ADAR1 Capital Management, LLC's portfolio?

ADAR1 Capital Management, LLC reported $410.61M of long equity holdings across 203 positions as of 2024-Q4. Top-10 holdings account for 46.7% of reported value.

What is ADAR1 Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/adar1-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →